Recovery Through Inspiration, Support, and Empowerment
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Jun 26, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new support program designed to help young adults aged 18 to 27 who have recently left a hospital or emergency room because of thoughts about suicide, a suicide attempt, depression, or anxiety. The goal is to see if this program can reduce suicidal thoughts, improve mood and anxiety, prevent the need to return to the hospital, and help participants on their path to recovery. The program offers extra education and support through one-on-one and group meetings led by people with lived experience, called Peer Support Specialists, along with local recovery organizations.
If you join the study, you will be placed in one of two groups for eight weeks. One group will receive the new support program, including personal meetings and group sessions. The other group will receive the usual care, which involves regular phone check-ins and information about medications and community resources. Throughout the study, your progress will be checked with assessments, and your medication use and any hospital visits will be tracked. This study is currently looking for participants who meet these criteria and do not have certain other diagnoses like schizophrenia or severe developmental disorders. It’s a chance to get extra support during an important time and help improve care for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chief complaint of suicidal ideation, suicide attempt, depression, and/or anxiety
- • discharged from inpatient care or from emergency department
- • men and women ages 18-27
- Exclusion Criteria:
- • primary diagnosis of: substance use disorder, schizophrenia spectrum, intellectual development disorder, autism spectrum disorder (level II or III)
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Joseph Guillory, M.D.
Principal Investigator
UT Southwestern Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported